Infectious Disease Point-of-Care Testing Market (2025-2031) | Share, Revenue, Growth, Forecast, Analysis, Trends, Value, Companies, Industry, Outlook, Size

Infectious Disease Point-of-Care Testing Market Highlights

Report Name	Infectious Disease Point-of-Care Testing Market
Report Category / Coverage	Global
CAGR	9.5%
Market Size	USD 15.4 Billion by 2031
Growing Sector	Healthcare
Forecast Period	2025-2031

Topics Covered in the Infectious Disease Point-of-Care Testing Market Report

The Infectious Disease Point-of-Care Testing market report thoroughly covers the market by applications, by technologies, by end-users and by regions. The report provides an unbiased and detailed analysis of the ongoing market trends, opportunities/high growth areas, and market drivers which would help the stakeholders to devise and align their market strategies according to the current and future market dynamics.

Infectious Disease Point-of-Care Testing Market Size & Analysis

The Infectious Disease Point-of-Care Testing (POCT) market has been experiencing significant growth over the past few years. As of 2025, the global market is valued at approximately $9.8 billion. Further, the Global Market is projected to expand at a CAGR of 9.5% from 2025 to 2031. Additionally, by 2031, the market size is expected to reach around $15.4 billion.

Infectious Disease Point-of-Care Testing Market Synopsis

The Infectious Disease Point-of-Care Testing (POCT) market is experiencing significant growth, driven by the increasing prevalence of infectious diseases, the demand for rapid diagnostic solutions, and advancements in testing technologies. This market segment includes a variety of tests for conditions such as COVID-19, influenza, and sexually transmitted infections, enabling quick and accurate results at the patient's location. The rise in home healthcare, telemedicine, and portable testing devices, alongside supportive government initiatives and funding for healthcare innovations, further propels market expansion. Moreover, the need for timely disease management and surveillance, especially highlighted by the COVID-19 pandemic, underscores the critical role of POCT in public health strategies worldwide. As a result, the market is projected to witness robust growth, with advancements in assay development and increased adoption in both developed and emerging economies.

According to 6Wresearch, Infectious Disease Point-of-Care Testing market size is projected to grow at a CAGR of 9.5% during 2025-2031. The growth of the Infectious Disease Point-of-Care Testing (POCT) market is primarily driven by several factors, including the increasing incidence of infectious diseases, a growing emphasis on early diagnosis and treatment, and the demand for rapid testing solutions, especially highlighted by the COVID-19 pandemic. Advances in technology, such as the development of portable and user-friendly diagnostic devices, also play a significant role in driving market growth. Furthermore, the rising trend of home healthcare and telemedicine is facilitating broader access to testing, making it more convenient for patients. However, the Infectious Disease Point-of-Care Testing industry faces challenges such as regulatory hurdles and the need for extensive validation of new tests, which can delay product approval. Additionally, disparities in healthcare infrastructure across regions may limit access to POCT in low-resource settings. Concerns regarding the accuracy and reliability of certain rapid tests can also hinder adoption, necessitating continuous improvements in testing methods to build trust among healthcare providers and patients alike.

Infectious Disease Point-of-Care Testing Market Trends

• Integration of Digital Health Technologies - Increasing use of mobile health (mHealth) applications and telehealth services to facilitate remote monitoring and testing.
• Rise of Multiplex Testing - Growing demand for multiplex assays that can detect multiple pathogens simultaneously, enhancing diagnostic efficiency.
• Shift Towards Decentralized Testing - Movement from traditional laboratory-based testing to decentralized POCT, allowing for testing closer to patients.
• Technological Advancements - Innovations in biosensors, microfluidics, and rapid test kits that improve the speed and accuracy of diagnostics.
• Increased Investment in R&D - Heightened focus on research and development to create novel testing solutions, driven by the urgency for rapid diagnostics.
• Regulatory Support and Funding - Enhanced government support and funding initiatives aimed at promoting the development and accessibility of POCT technologies.
• Growing Focus on Infectious Disease Surveillance - Increased awareness of the need for effective infectious disease monitoring and control, especially post-pandemic.
• Emergence of Home Testing Kits - Rising popularity of at-home testing kits for various infectious diseases, providing convenience and privacy for patients.

Investment Opportunities in the Infectious Disease Point-of-Care Testing Market

• Development of Multiplex Testing Solutions - Investing in technologies that allow for the simultaneous detection of multiple infectious agents, enhancing diagnostic capabilities.
• Expansion of Home Testing Kits - Opportunities in creating and marketing at-home testing solutions for infectious diseases, catering to the growing demand for convenience and privacy.
• Digital Health Integration - Investing in platforms that integrate POCT with digital health technologies, such as telemedicine and mobile health applications, to enhance patient engagement and monitoring.
• Innovations in Testing Technologies - Funding research and development of advanced diagnostic technologies, including biosensors and microfluidics, to improve test accuracy and speed.
• Expansion in Emerging Markets - Exploring opportunities in underserved markets with a rising need for accessible diagnostic solutions, especially in Asia-Pacific and Africa.
• Partnerships with Healthcare Institutions - Collaborating with hospitals, clinics, and public health organizations to implement POCT solutions, improving disease management and patient outcomes.
• Regulatory Consulting Services - Providing expertise to navigate the regulatory landscape for new POCT products, facilitating faster market entry.
• Supply Chain Improvements - Investing in supply chain logistics to ensure timely distribution and availability of testing kits, particularly in remote or rural areas.
• Education and Training Programs - Funding initiatives that provide training for healthcare professionals on the effective use of POCT technologies, improving test adoption and accuracy.

Key Players in the Infectious Disease Point-of-Care Testing Market

Key companies in the Infectious Disease Point-of-Care Testing (POCT) market include Abbott Laboratories, known for its rapid diagnostics solutions; Roche Diagnostics, which offers a range of innovative testing platforms; Thermo Fisher Scientific, focusing on advanced diagnostic technologies; Siemens Healthineers, providing comprehensive POCT systems; and BD (Becton, Dickinson and Company), recognized for its extensive portfolio of infectious disease tests. Other notable players include Cepheid, specializing in molecular testing; Quidel Corporation, known for rapid immunoassays; Hologic, which develops diagnostic solutions for women's health; and BioMerieux, focusing on infectious disease diagnostics and antimicrobial susceptibility testing. Additionally, some of these players hold majority of the Infectious Disease Point-of-Care Testing market share. Moreover, these companies are at the forefront of innovation, driving advancements in POCT technologies and expanding their product offerings to meet the growing demand for rapid and accurate infectious disease diagnostics.

Government Regulations in the Infectious Disease Point-of-Care Testing Market

Government regulations play a crucial role in the Infectious Disease Point-of-Care Testing (POCT) market, primarily aimed at ensuring the safety, efficacy, and quality of diagnostic products. Regulatory bodies such as the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), and other national health authorities establish stringent guidelines for the development, testing, and approval of POCT devices. These regulations encompass various aspects, including pre-market submissions, clinical performance evaluations, labeling requirements, and post-market surveillance. Recently, many countries have expedited the regulatory processes for COVID-19 testing, which may lead to a broader acceptance of rapid diagnostic tests in the future. Further, these initiatives have further boosted the Infectious Disease Point-of-Care Testing market revenues. Furthermore, governments often implement reimbursement policies that can influence market dynamics, as well as initiatives to promote innovation in diagnostic technologies through funding and grants. Compliance with these regulations is essential for manufacturers to gain market access and build trust with healthcare providers and patients alike.

Future Insights of the Infectious Disease Point-of-Care Testing Market

The future of the Infectious Disease Point-of-Care Testing (POCT) market appears promising, with expectations for significant advancements driven by ongoing technological innovations and a heightened focus on personalized healthcare. As the demand for rapid and accurate diagnostics continues to grow, we anticipate an increase in the adoption of novel testing modalities, such as molecular diagnostics and biosensors, that deliver results within minutes. Integration with digital health platforms will facilitate real-time monitoring and data sharing, enhancing patient outcomes and enabling effective disease management. Furthermore, the market is likely to see an expansion in testing for a broader range of infectious diseases, including emerging pathogens and antimicrobial resistance monitoring. As regulatory frameworks evolve to accommodate rapid test approvals, and with increasing investments in healthcare infrastructure, especially in emerging markets, the POCT landscape will become more accessible and versatile, ultimately transforming how infectious diseases are diagnosed and managed.

Market Segmentation Analysis

The report offers a comprehensive study of the subsequent market segments and their leading categories.

North America to Dominate the Market - By Regions

According to Ravi Bhandari, Research Head, 6Wresearch, North America is a key performing region in the Infectious Disease Point-of-Care Testing (POCT) market, primarily driven by advanced healthcare infrastructure, high levels of investment in research and development, and a strong focus on rapid diagnostic solutions. The United States, in particular, leads the market due to its significant healthcare expenditure and the presence of numerous prominent diagnostic companies that are at the forefront of innovation. The region has witnessed accelerated adoption of POCT technologies, especially in response to the COVID-19 pandemic, which has emphasized the need for timely and accurate testing. Additionally, favorable government initiatives and regulatory support have facilitated the development and approval of new diagnostic tests, further propelling market growth.

Liver Disease Category to Dominate the Market - By Application

The liver disease segment within the Infectious Disease Point-of-Care Testing (POCT) market is experiencing notable growth, driven by the rising prevalence of liver-related conditions, such as hepatitis and non-alcoholic fatty liver disease (NAFLD). Increasing awareness of liver health and the need for early detection and management are propelling demand for rapid diagnostic solutions that can provide timely results at the point of care. Technological advancements in biomarker identification and assay development are enhancing the accuracy and speed of liver disease diagnostics, making it easier for healthcare providers to initiate appropriate treatment plans promptly. Furthermore, the integration of POCT in routine health screenings and preventive healthcare initiatives is contributing to the segment's expansion.

Key Attractiveness of the Report

• 10 Years Market Numbers.
• Historical Data Starting from 2021 to 2024.
• Base Year - 2024.
• Forecast Data until 2031.
• Key Performance Indicators Impacting the Market.
• Major Upcoming Developments and Projects.

Key Highlights of the Report:

• Infectious Disease Point-of-Care Testing Market Overview
• Infectious Disease Point-of-Care Testing Market Outlook
• Infectious Disease Point-of-Care Testing Market Forecast
• Historical Data of Infectious Disease Point-of-care Testing Market Revenues & Volume for the Period 2021-2031
• Infectious Disease Point-of-care Testing Market Size and Infectious Disease Point-of-care Testing Market Forecast of Revenues & Volume, Until 2031
• Historical Data of Infectious Disease Point-of-care Testing Market Revenues & Volume, By End-users, for the Period 2021-2031
• Market Size & Forecast of Infectious Disease Point-of-care Testing Market Revenues & Volume, By End-users, Until 2031
• Historical Data of Infectious Disease Point-of-care Testing Market Revenues & Volume, By Applications, for the Period 2021-2031
• Market Size & Forecast of Infectious Disease Point-of-care Testing Market Revenues & Volume, By Applications, Until 2031
• Historical Data of Infectious Disease Point-of-care Testing Market Revenues & Volume, by Technology, for the Period 2021-2031
• Market Size & Forecast of Infectious Disease Point-of-care Testing Market Revenues & Volume, by Technology, Until 2031
• Historical Data of Infectious Disease Point-of-care Testing Market Revenues, By Regions, for the Period 2021-2031
• Market Size & Forecast of Infectious Disease Point-of-care Testing Market Revenues, By Regions, Until 2031
• Historical Data of Asia Pacific Infectious Disease Point-of-care Testing Market Revenues, for the Period 2021-2031
• Market Size & Forecast of Asia Pacific Infectious Disease Point-of-care Testing Market Revenues, Until 2031
• Historical Data of Latin America Infectious Disease Point-of-care Testing Market Revenues, for the Period 2021-2031
• Market Size & Forecast of Latin America Infectious Disease Point-of-care Testing Market Revenues, Until 2031
• Historical Data of Europe Infectious Disease Point-of-care Testing Market Revenues, for the Period 2021-2031
• Market Size & Forecast of Europe Infectious Disease Point-of-care Testing Market Revenues, Until 2031
• Historical Data of Middle East Infectious Disease Point-of-care Testing Market Revenues, for the Period 2021-2031
• Market Size & Forecast of Middle East Infectious Disease Point-of-care Testing Market Revenues, Until 2031
• Historical Data of North America Infectious Disease Point-of-care Testing Market Revenues, for the Period 2021-2031
• Market Size & Forecast of North America Infectious Disease Point-of-care Testing Market Revenues, Until 2031
• Historical Data of Africa Infectious Disease Point-of-care Testing Market Revenues, for the Period 2021-2031
• Market Size & Forecast of Africa Infectious Disease Point-of-care Testing Market Revenues, Until 2031
• Market Drivers and Restraints
• Infectious Disease Point-of-care Testing Market Trends and Industry Life Cycle
• Porter’s Five Force Analysis
• Market Opportunity Assessment
• Infectious Disease Point-of-care Testing Market Share, By Players
• Infectious Disease Point-of-care Testing Market Share, By Regions
• Infectious Disease Point-of-care Testing Market Overview on Competitive Benchmarking
• Company Profiles
• Key Strategic Recommendations

Markets Covered

The Infectious Disease Point-of-Care Testing market report provides a detailed analysis of the following market segments -

By Applications

• Tropical Disease
• Liver Disease
• Respiratory Disease
• Sexual Disorders
• Others

By Technologies

• Lateral Flow
• Flow-through
• Agglutination Assays
• Solid Phase

By End-Users

• Diagnostic Laboratories
• Hospitals
• Home-care Settings
• Others

By Regions

• Asia Pacific
• North America
• Latin America
• Europe
• Middle East
• Africa